Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

Go back to Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
(NASDAQ: SPTX) Delayed: 24.91 +1.30 (5.51%)
Previous Close $23.61    52 Week High
Open $23.66    52 Week Low
Day High $25.21    P/E N/A 
Day Low $23.65    EPS
Volume 156,428